Cargando…

Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production

A live-attenuated, human vaccine against mosquito-borne yellow fever virus has been available since the 1930s. The vaccine provides long-lasting immunity and consistent mass vaccination campaigns counter viral spread. However, traditional egg-based vaccine manufacturing requires about 12 months and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolay, Alexander, Léon, Arnaud, Schwamborn, Klaus, Genzel, Yvonne, Reichl, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153634/
https://www.ncbi.nlm.nih.gov/pubmed/30091043
http://dx.doi.org/10.1007/s00253-018-9275-z

Ejemplares similares